Update on the Diagnosis and Treatment of Combined Hepatocellular Cholangiocarcinoma.

Authors:
Chu KJ; Kawaguchi Y; Wang H; Jiang XQ; Hasegawa K.

Journal:
J Clin Transl Hepatol

Publication Year: 2023

DOI:
10.14218/JCTH.2023.00189

PMCID:
PMC10851068

PMID:
38343605

View on PubMed View on PMC View Publisher
Journal Information

Full Title: J Clin Transl Hepatol

Abbreviation: J Clin Transl Hepatol

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Gastroenterology & Hepatology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
A Novel Algorithm for Streamlining Diagnosis of Advanced Liver Fibrosis in CHB Patients with Concur…
Xu X; Rui F; Ni W and 3 more (2024) - Transparency Score: 3/6
Approaching the Sarcopenic Patient with Nonalcoholic Steatohepatitis-related Cirrhosis.
Gallo P; Flagiello V; Falcomatà A and 5 more (2024) - Transparency Score: 2/6
Focal Nodular Hyperplasia: A Comprehensive Review with a Particular Focus on Pathogenesis and Compl…
Villavicencio Kim J; Wu GY. (2024) - Transparency Score: 2/6
Hepatocellular Carcinoma Incidence and Mortality in the USA by Sex, Age, and Race: A Nationwide Ana…
Abboud Y; Ismail M; Khan H and 4 more (2024) - Transparency Score: 2/6
Improving the Conversion Success Rate of Hepatocellular Carcinoma: Focus on the Use of Combination …
Chen QF; Chen S; Chen M and 2 more (2024) - Transparency Score: 3/6
View All Papers from This Journal
Transparency Score
2/6
33.3% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"The authors have no conflict of interests related to this publication."

Funding Disclosure
Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025